Optimizing Antiplatelet Therapy Around Noncardiac Surgical Procedures

Objective: The perioperative management of antiplatelet agents (APA) in coronary patients remains a challenge for anesthesiologists and cardiologists due to the delicate balance between bleeding and thrombotic risks. This study aimed to assess current practices at CHU IBN ROCHD in Casablanca.Methods: A cross-sectional observational study was conducted between September and December 2023 among anesthesiologists and cardiologists, using an electronic questionnaire. Data were analyzed descriptively using R Studio software.Results: Among 93 participants (54% anesthesiologists, 46% cardiologists), wide variability in practice was observed. Most anesthesiologists discontinued aspirin even in self-medication cases, whereas cardiologists favored a more individualized approach. Management of patients under dual antiplatelet therapy (DAPT) was inconsistent, especially in emergency surgery settings. Specialist consultation was reported in only 54% of cases by anesthesiologists.Conclusion: This study highlights the lack of consensus and the urgent need for interdisciplinary coordination and locally adapted protocols to improve perioperative safety in patients receiving antiplatelet therapy.